Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 3 studies | 20% ± 3% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 4% | |
macrophage | 3 studies | 23% ± 6% |
Insufficient scRNA-seq data for expression of SIGLEC7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 194.92 | 575 / 578 | 81% | 3.36 | 940 / 1155 |
breast | 81% | 50.79 | 373 / 459 | 81% | 2.32 | 902 / 1118 |
liver | 99% | 120.30 | 224 / 226 | 42% | 1.04 | 170 / 406 |
intestine | 80% | 54.30 | 771 / 966 | 54% | 1.65 | 287 / 527 |
bladder | 81% | 57.00 | 17 / 21 | 51% | 1.55 | 258 / 504 |
kidney | 52% | 39.17 | 46 / 89 | 77% | 3.68 | 695 / 901 |
adrenal gland | 95% | 127.52 | 245 / 258 | 25% | 0.62 | 58 / 230 |
stomach | 51% | 24.46 | 183 / 359 | 67% | 2.28 | 191 / 286 |
ovary | 38% | 17.36 | 68 / 180 | 75% | 2.59 | 324 / 430 |
thymus | 50% | 19.77 | 325 / 653 | 56% | 1.39 | 341 / 605 |
pancreas | 28% | 11.61 | 92 / 328 | 75% | 2.56 | 133 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.55 | 29 / 29 |
spleen | 100% | 820.49 | 241 / 241 | 0% | 0 | 0 / 0 |
uterus | 46% | 18.68 | 79 / 170 | 51% | 1.21 | 234 / 459 |
prostate | 65% | 31.02 | 160 / 245 | 32% | 0.55 | 159 / 502 |
esophagus | 47% | 21.91 | 683 / 1445 | 49% | 1.06 | 90 / 183 |
adipose | 93% | 97.80 | 1115 / 1204 | 0% | 0 | 0 / 0 |
brain | 22% | 13.09 | 581 / 2642 | 68% | 3.08 | 478 / 705 |
peripheral blood | 83% | 763.73 | 773 / 929 | 0% | 0 | 0 / 0 |
skin | 9% | 2.61 | 155 / 1809 | 72% | 3.22 | 339 / 472 |
blood vessel | 65% | 53.67 | 868 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 1.92 | 29 / 45 |
heart | 63% | 33.69 | 545 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 0.53 | 20 / 80 |
muscle | 4% | 1.38 | 35 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007155 | Biological process | cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0033691 | Molecular function | sialic acid binding |
Gene name | SIGLEC7 |
Protein name | Sialic acid binding Ig like lectin 7 Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328) |
Synonyms | AIRM1 |
Description | FUNCTION: Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acid. Also binds disialogangliosides (disialogalactosyl globoside, disialyl lactotetraosylceramide and disialyl GalNAc lactotetraoslylceramide). The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Mediates inhibition of natural killer cells cytotoxicity. May play a role in hemopoiesis. Inhibits differentiation of CD34+ cell precursors towards myelomonocytic cell lineage and proliferation of leukemic myeloid cells (in vitro). . |
Accessions | ENST00000601682.1 ENST00000600577.1 [Q9Y286-4] ENST00000305628.7 [Q9Y286-2] ENST00000536156.5 [Q9Y286-3] Q9Y286 ENST00000317643.10 [Q9Y286-1] M0QY65 |